Výsledky vyhledávání - "Mallory C Cowart"

Implementation of an Automatic 48-Hour Vancomycin Hard-Stop in a Pediatric Community Hospital

Autor: Mallory C, Cowart, Danielle, Miller, Federico R, Laham, Alejandro, Jordan-Villegas

Publikováno v: J Pediatr Pharmacol Ther

OBJECTIVE Previous studies evaluating antimicrobial time-outs and required stop dates on antimicrobial orders indicate that these strategies are effective in decreasing antimicrobial duration and cost without a negative impact on patient outcomes. Fe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab11cab60391175fd67bc1b503e29b9
https://doi.org/10.5863/1551-6776-27.2.147

Zobrazit plný text záznamu

Severe Acute Respiratory Syndrome Coronavirus-2 Pneumonia in a Newborn Treated With Remdesivir and Coronavirus Disease 2019 Convalescent Plasma

Autor: Wang Leung Cheung, Alejandro Jordan-Villegas, Federico R. Laham, Michael J McMahan, Andrew J Hopwood, Liliana D Gutierrez, Michael R Gomez, Mallory C Cowart, Wilfredo Vega-Montalvo

Publikováno v: Journal of the Pediatric Infectious Diseases Society

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel pandemic virus. Mounting evidence supports the possibility of vertical transmission, which at the present time appears to be rare. We report a newborn with vertically acquired SA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbb2ee495201629fe567fb656f045dbc
https://doi.org/10.1093/jpids/piaa165

Zobrazit plný text záznamu

High‐level ceftaroline resistance in a paediatric patient with invasive methicillin‐resistant Staphylococcus aureus infection without previous ceftaroline exposure

Autor: Mallory C Cowart, Federico R. Laham, Chelsea L Ferguson, Alejandro Jordan-Villegas

Publikováno v: Journal of Clinical Pharmacy and Therapeutics. 46:524-527

What is known an objective Our objective is to report a paediatric case of high-level ceftaroline resistance without previous ceftaroline exposure. Case description A 20-month-old, 12 kg, female with invasive MRSA infection presented with high-level

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2008b163c4552d8829b147f72380e77b
https://doi.org/10.1111/jcpt.13316

Zobrazit plný text záznamu

Optimization of Aztreonam in Combination With Ceftazidime/Avibactam in a Cystic Fibrosis Patient With Chronic Stenotrophomonas maltophilia Pneumonia Using Therapeutic Drug Monitoring: A Case Study

Autor: Chelsea L Ferguson, Mallory C Cowart

Publikováno v: Therapeutic drug monitoring. 43(2)

In this clinician-therapeutic drug monitoring (TDM) consultant interaction, the authors describe the use of TDM in an 11-year-old female patient with cystic fibrosis receiving ceftazidime/avibactam and aztreonam for the treatment of persistent pulmon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17e81af46ad03faf657ba7fc25140b8d
https://pubmed.ncbi.nlm.nih.gov/33315762

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání